Derek Lowe – Analytics Author
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He’s worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer’s, diabetes, osteoporosis and other diseases.
To contact Derek, email him directly: [email protected] (mailto:[email protected])
Followers: 3690 / Contributor since: 2007
Summary Attempts earlier in the pandemic to dose people with polyclonal antibody fractions from recovered patients really didn’t work out so well – the efficacy was quite disappointing. And since … Read more
Summary Three recent independent in-vitro studies show that ADG20 has neutralization activity against Omicron. ADG20 being explored in the phase 2/3 STAMP and EVADE studies for treatment and prevention of … Read more